ACTIVE

MARC-PHARMA

Financial year 2025 · Closed on 31/12/2025

Net result16,2 k €
Gross margin23,6 k €
Equity21,2 k €

Identity

Source · BCE/KBO

MARC-PHARMA is a Private limited company incorporated in 2024. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Walcourt.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 1017.943.140
Incorporation
26/12/2024
Legal form
Private limited company
Registered office
Route de Philippeville(Tar) 57
5651 Walcourt · WallonieSee on map
Contributed capital
5 000,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 1 filing

Trend over 1 financial year

2025
Income statement
Gross margin23,6 k €
EBITDA23,6 k €
Operating result20,5 k €
Net result16,2 k €
Balance sheet
Equity21,2 k €
Total assets36,1 k €
Cash51,1 €
Debts14,9 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Marc-Louis FADIHERBE
Director

Other companies at this address

Route de Philippeville(Tar) 57 5651 Walcourt
CompanyCBE no.
ASSEC-IT● Active
0479.092.502
0797.425.023
CHIMATEX● Active
0434.634.531
CSB CONSEILS● Active
0780.619.871
0800.754.596
ECONOMIA● Active
0808.565.472
ExecAdvice● Active
0832.232.086
Ferme VEREECKE● Active
0888.595.719
0849.777.012
0628.601.075
0876.883.859
1001.113.739
0635.529.746
0543.743.297
Marchimmo● Active
0692.626.124
MICHMAR FARMING● Active
1035.468.268
NATURE EVENTS● Active
1025.462.521
0430.378.607
0470.776.632
0479.323.520

Full financial information

Source · NBB
2025
Type of accountMicro model
Start of the financial year01/11/2024
Closing of the financial year31/12/2025
Length of the financial year14 months
Filing date10/07/2026
General meeting15/05/2026
Currency of the financial yearEUR
NBB quality labelSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 1 filing
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202515/05/202610/07/2026FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

DirectorMandates in this companyPeriod
Marc-Louis FADIHERBE
Director

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other30/12/2024
    CONSTITUTION
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings1 filing
Mandates
Marc-Louis FADIHERBE
202420252026
MARC-PHARMA
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Route de Philippeville(Tar) 57, 5651 Thy-le-ChâteauCurrent
CBE
Route de Philppeville 57, 5650 Walcourt
accounts 2025
Accounts 2025 · 2026-00296598

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
MARC-PHARMACurrent
accounts 2025
Accounts 2025 · 2026-00296598

Events

  1. 2025
    Annual accounts 202516,2 k €
  2. 26/12/2024
    IncorporationPrivate limited company